These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 20877131)
1. Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians. Boivin AA; Cardinal H; Barama A; Pichette V; Hébert MJ; Roger M Drug Metab Pharmacokinet; 2010; 25(5):508-15. PubMed ID: 20877131 [TBL] [Abstract][Full Text] [Related]
2. Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure. Endo S; Fukahori A; Tokuhiro S; Shinagawa A; Walker J; Yoshihara K; Ishizuka H; Ieiri I; Sugiyama Y J Hum Genet; 2012 Aug; 57(8):531-44. PubMed ID: 22695893 [TBL] [Abstract][Full Text] [Related]
3. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883 [TBL] [Abstract][Full Text] [Related]
4. Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups. Namgoong S; Cheong HS; Kim JO; Kim LH; Na HS; Koh IS; Chung MW; Shin HD Environ Toxicol Pharmacol; 2015 Nov; 40(3):692-7. PubMed ID: 26409184 [TBL] [Abstract][Full Text] [Related]
5. Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene. Trdan Lušin T; Stieger B; Marc J; Mrhar A; Trontelj J; Zavratnik A; Ostanek B J Transl Med; 2012 Apr; 10():76. PubMed ID: 22533838 [TBL] [Abstract][Full Text] [Related]
6. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity. DeGorter MK; Ho RH; Leake BF; Tirona RG; Kim RB Mol Pharm; 2012 Apr; 9(4):986-95. PubMed ID: 22352740 [TBL] [Abstract][Full Text] [Related]
7. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms. Hartkoorn RC; Kwan WS; Shallcross V; Chaikan A; Liptrott N; Egan D; Sora ES; James CE; Gibbons S; Bray PG; Back DJ; Khoo SH; Owen A Pharmacogenet Genomics; 2010 Feb; 20(2):112-20. PubMed ID: 20051929 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). Letschert K; Keppler D; König J Pharmacogenetics; 2004 Jul; 14(7):441-52. PubMed ID: 15226676 [TBL] [Abstract][Full Text] [Related]
9. Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population. Pasanen MK; Backman JT; Neuvonen PJ; Niemi M Eur J Clin Pharmacol; 2006 Jun; 62(6):409-15. PubMed ID: 16758257 [TBL] [Abstract][Full Text] [Related]
10. Genetic variations and frequencies of major haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than *15. Kim SR; Saito Y; Sai K; Kurose K; Maekawa K; Kaniwa N; Ozawa S; Kamatani N; Shirao K; Yamamoto N; Hamaguchi T; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Ohtsu A; Saijo N; Sawada J Drug Metab Pharmacokinet; 2007 Dec; 22(6):456-61. PubMed ID: 18159134 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Ieiri I; Higuchi S; Sugiyama Y Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):703-29. PubMed ID: 19442037 [TBL] [Abstract][Full Text] [Related]
12. Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. Miura M; Satoh S; Inoue K; Kagaya H; Saito M; Inoue T; Suzuki T; Habuchi T Eur J Clin Pharmacol; 2007 Dec; 63(12):1161-9. PubMed ID: 17906856 [TBL] [Abstract][Full Text] [Related]
13. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Smith NF; Figg WD; Sparreboom A Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454 [TBL] [Abstract][Full Text] [Related]
14. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver. Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430 [TBL] [Abstract][Full Text] [Related]
15. Amino acid residues in transmembrane domain 10 of organic anion transporting polypeptide 1B3 are critical for cholecystokinin octapeptide transport. Gui C; Hagenbuch B Biochemistry; 2008 Sep; 47(35):9090-7. PubMed ID: 18690707 [TBL] [Abstract][Full Text] [Related]
16. SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome. Cheng YY; Chang KC; Chen PL; Yeung CY; Liou BY; Chen HL J Formos Med Assoc; 2023 Jul; 122(7):648-652. PubMed ID: 36964102 [TBL] [Abstract][Full Text] [Related]
17. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Kindla J; Müller F; Mieth M; Fromm MF; König J Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119 [TBL] [Abstract][Full Text] [Related]
18. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Niemi M; Pasanen MK; Neuvonen PJ Pharmacol Rev; 2011 Mar; 63(1):157-81. PubMed ID: 21245207 [TBL] [Abstract][Full Text] [Related]
19. OATP1B3-1B7, a novel organic anion transporting polypeptide, is modulated by FXR ligands and transports bile acids. Malagnino V; Hussner J; Issa A; Midzic A; Meyer Zu Schwabedissen HE Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G751-G762. PubMed ID: 31509437 [TBL] [Abstract][Full Text] [Related]
20. The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro. Tsakalozou E; Adane ED; Kuo KL; Daily A; Moscow JA; Leggas M Drug Metab Dispos; 2013 Jul; 41(7):1404-13. PubMed ID: 23620484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]